Radiation dose estimates for interstitial radiocolloid lymphoscintigraphy

Area of Science:

• Nuclear medicine
• Radiopharmacology
• Medical imaging

Background:

• Interstitial lymphoscintigraphy is a crucial diagnostic technique.
• Understanding radiocolloid behavior at injection sites is vital for accurate dosimetry.
• Technetium-99m (99mTc) antimony sulfide colloid is commonly used.

Purpose of the Study:

• To assess the spatial distribution and clearance of radioactivity from injection sites.
• To determine absorbed radiation dose estimates in patients undergoing lymphoscintigraphy.
• To compare radiocolloid behavior across different injection locations.

Main Methods:

• Patients underwent interstitial lymphoscintigraphy using 99mTc-antimony sulfide colloid.
• Radioactivity levels at injection sites and lymph nodes were measured over time.
• Absorbed radiation doses were calculated for various anatomical locations.

Main Results:

• Radioactivity clearance and spatial distribution varied significantly depending on the injection site.
• Maximum absorbed dose to the rectus sheath injection site was 45.6 rads.
• Maximum absorbed dose to individual lymph nodes was 21 rads for internal mammary lymphoscintigraphy.

Conclusions:

• Injection site selection impacts radiocolloid behavior and radiation dosimetry in lymphoscintigraphy.
• Accurate dose estimations are crucial for patient safety in nuclear medicine procedures.
• Further studies can optimize radiocolloid administration for improved diagnostic accuracy and safety.